Effects of Fetal, Infant, and Early Childhood Exposures on Adult Cancer Risk in Women

Sponsor
National Institutes of Health Clinical Center (CC) (NIH)
Overall Status
Completed
CT.gov ID
NCT00559039
Collaborator
National Cancer Institute (NCI) (NIH)
128,700
1
72
1787.9

Study Details

Study Description

Brief Summary

RATIONALE: Gathering information about pregnancy, infancy, and early childhood exposures may help doctors identify cancer risk factors, and may help the study of cancer.

PURPOSE: This natural history study is looking at the effects of fetal, infant, and early childhood exposures on adult cancer risk in women.

Condition or Disease Intervention/Treatment Phase
  • Other: questionnaire administration
  • Procedure: evaluation of cancer risk factors

Detailed Description

OBJECTIVES:
  • Determine if fetal, infant, and early childhood exposures are associated with adult cancer risk in women.

OUTLINE: Mothers of nurses complete questionnaires to collect maternal data, such as pregnancy weight gain, diet during pregnancy, maternal pre-eclampsia, gestational diabetes, gestational age at birth, birth weight, and infant feeding practices. Maternal data is linked to other data collected from critical time periods in the nurses's life cycle, such as menarche, first pregnancy, or adult dietary intake.

Study Design

Study Type:
Observational
Anticipated Enrollment :
128700 participants
Official Title:
Fetal, Infant and Early Childhood Antecedents of Cancer in Women: Maternal Cohort Study of the Nurses' Health Studies
Study Start Date :
Oct 1, 2000
Actual Study Completion Date :
Oct 1, 2006

Outcome Measures

Primary Outcome Measures

  1. Diagnosis of incident cancers and other chronic diseases []

  2. Mortality []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 89 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
DISEASE CHARACTERISTICS:
  • Mother of a nurse who is a participant in the Nurses' Health Studies I and II

  • Nurse free of cancer in the year 2000

PATIENT CHARACTERISTICS:
  • Not specified
PRIOR CONCURRENT THERAPY:
  • Not specified

Contacts and Locations

Locations

Site City State Country Postal Code
1 Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda Maryland United States 20892-1182

Sponsors and Collaborators

  • National Institutes of Health Clinical Center (CC)
  • National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Michele R. Forman, PhD, M.D. Anderson Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00559039
Other Study ID Numbers:
  • 999901015
  • 01-C-N015
  • CDR0000565931
  • NCT00340145
First Posted:
Nov 16, 2007
Last Update Posted:
Mar 8, 2012
Last Verified:
Mar 1, 2012
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 8, 2012